You are here

Alina Ainbinder


Pietrangelo L, D’Incecco A, Ainbinder A, et al. Age-dependent uncoupling of mitochondria from Ca2+ release units in skeletal muscle. Oncotarget. 2015;6(34): 35358-35371.

Ainbinder A, Boncompagni S, Protasi F, and Dirksen RT. Role of mitofusin-2 in mitochondrial localization and calcium uptake in skeletal muscle. Cell Calcium. 2014;57(1):14-24.

Lanner JT, Georgiou DK, Dagnino-Acosta A, Ainbinder A, et al. AICAR prevents heat induced sudden death in RyR1 mutant mice independent of AMPK activation. Nat Med. 2011;18(2): 244-251.

Alina Ainbinder, Ph.D.

Alina Ainbinder is a research scientist I in the Diabetes Research Group of the Broad Institute of MIT and Harvard, where she works under the direction of Suzanne Jacobs to study genetic perturbations of type 2 diabetes, with specific emphasis on the identification of causal gene variants as well as the molecular, cellular, and physiological mechanisms that lead to disease. Her goal is to identify potential therapeutic targets for people with or at high risk for developing type 2 diabetes.

Prior to joining the Broad Institute in July 2017, Ainbinder completed postdoctoral research at the University of Rochester, where she also served as a lecturer in cellular and molecular physiology.

Ainbinder received her Ph.D. in pharmacology at the University of Rochester and also holds a B.Sc. (Hons.) in biotechnology engineering from Ort Braude College of Engineering, Karmiel, Israel.

Contact Alina Ainbinder via email at